Best Growth Stocks For 2018

This small cap Top Pick is a regional bank based in California that boasts strong scores in our Quadrix ranking system for operating momentum and share-price action, notes Richard Moroney, editor of Upside.

Preferred Bank (PFBC) has surged 54% in the past year but still trades at a modest discount to the median S&P 1500 regional bank, based on both trailing earnings and estimated 2017 profits.

Regional banks have coped with unusually low interest rates since the financial meltdown and are now positioned to benefit from the Federal Reserve’s plan to ramp its pace of rate hikes in 2017.

Even in a low-rate environment, Preferred Bank has generated robust growth, with annual per share profits up in five of the past six years and annual revenue up in five consecutive years.

For the first nine months of 2016, Preferred Bank delivered 16% higher profits and 29% higher revenue, as an expanding deposit base helped the bank increase its loan portfolio.

Best Growth Stocks For 2018: Rockwell Medical Technologies Inc.(RMTI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Rockwell Medical (RMTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Growth Stocks For 2018: Geopark Ltd(GPRK)

Advisors’ Opinion:

  • [By Max Byerly]

    Canaccord Genuity reaffirmed their buy rating on shares of Geopark (NYSE:GPRK) in a research note published on Tuesday morning.

    “We expect the Street to raise its estimates once again on the back of these strong results.”,” the firm’s analyst wrote.

Best Growth Stocks For 2018: Physicians Realty Trust(DOC)

Advisors’ Opinion:

  • [By Lee Jackson]

    Physicians Realty Trust (NYSE: DOC) investors receive a 6.05% yield. Shares traded at $15.15 early Thursday. The 52-week range is $14.31 to $21.85, and the posted consensus price objective is $17.59.

  • [By Logan Wallace]

    HL Financial Services LLC acquired a new position in Physicians Realty Trust (NYSE:DOC) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 55,982 shares of the real estate investment trust’s stock, valued at approximately $872,000.

  • [By Max Byerly]

    Physicians Realty Trust (NYSE:DOC) had its price target decreased by KeyCorp from $20.00 to $17.00 in a report issued on Tuesday, MarketBeat reports. KeyCorp currently has a buy rating on the real estate investment trust’s stock. KeyCorp also issued estimates for Physicians Realty Trust’s FY2018 earnings at $1.10 EPS and FY2019 earnings at $1.12 EPS.

Leave a Reply

Your email address will not be published. Required fields are marked *